Monk BJ, Colombo N, Tewari KS, Dubot C, et al. First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826. J Clin Oncol 2023 Nov 1:JCO2300914. doi: 10.1200/JCO.23.00914.
PMID: 37910822